TM
Tianjin Medical University Cancer Institute and Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Tianjin Medical University Cancer Institute and Hospital brings 15 presentations to ASH 2026 in New Orleans. Its program centres on lymphoma, especially diffuse large B-cell lymphoma, and the drug combinations used to treat it. It also reports early trials of allogeneic CAR T-cell therapies and an EZH1/2 inhibitor.
| Organization | ASH 2026 Attendance |
|---|---|
TM Tianjin Medical University Cancer Institute and Hospital Tianjin, China | |
Cancer institute and hospital in Tianjin, China. | Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Tianjin Medical University Cancer Institute and Hospital
Tell us what you sell and we’ll find the people at Tianjin Medical University Cancer Institute and Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction